- Country: Chile
- Summary: Buy by Medication Supply Table 3 Letter G
- CLT Ref No: 120898994
- Deadline: 14 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CLP 375000000
- Notice Type: Tender
- Document Ref. No.: 1058132-29-LR25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Buy for supply of medicines required for patient treatments treated at the Las Higueras de Talcahuano hospital, as indicated by the clinical professional.
PRODUCTS OR SERVICES: Sodium, isoflurano, acyclovir, ferrous fuma sulf, tacrolimo, atropine sulfate, atropine sulfate, Zopiclone, melatonin, sildenafil citrate, distilled water for irrigation, hyaluronidase, slighttam, risperidone, chorionic gonadotropin, BCG vaccine, chlorhexidine gluconate, iodized povidone, lindano, valproic acid, potassium gluconate, mebeverine hydrochloride ferrous, furosemide, Ciproheptadine hydrochloride, Budesonide - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBuy by Medication Supply Table 3 Letter G - Chile Tender
The TALCAHUANO HOSPITAL HEALTH SERVICE, a Government sector organization in Chile, has announced a new tender for Buy by Medication Supply Table 3 Letter G. This tender is published on ChileTenders under CLT Ref No: 120898994 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-14.
The estimated tender value is CLP 375000000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
